- In April 2025, Samsung Electronics announced a collaboration with Stanford Medicine to enhance its Galaxy Watch's sleep apnea detection capabilities. This partnership aims to integrate advanced artificial intelligence into the existing obstructive sleep apnea (OSA) feature, which has already received De Novo authorization from the U.S. Food and Drug Administration. The initiative seeks to provide users with continuous monitoring and timely interventions for sleep health. The expanded feature is expected to be available in 29 markets globally, including Brazil, by late April 2025. This development positions Samsung at the forefront of wearable health technology, potentially transforming sleep apnea management and setting a new standard in digital health solutions.
- In April 2025, Somnology, in collaboration with Samsung, launched a hybrid sleep care model integrating telehealth services with asynchronous support. This innovative solution leverages Samsung's advanced wearable technology and Somnology's proprietary sleep reports to provide personalized, accessible sleep health management. The collaboration debuted at HLTH 2024 and was showcased at HIMSS 2025, introducing the 'sleepbox'—a comprehensive sleep solution combining AI-powered insights with FDA-cleared sleep apnea detection. By bridging gaps in traditional sleep care, this initiative aims to accelerate access to critical insights, enabling timely intervention and reducing the risk of untreated symptoms. The seamless integration with the Galaxy Watch 7 enhances user experience, making cutting-edge sleep health solutions more accessible worldwide
- In February 2025, VitalConnect secured USD 100 million in funding to accelerate the commercialization of its VitalPatch, a wearable cardiac monitoring device. Unlike traditional Holter monitors, the VitalPatch offers real-time monitoring of 21 cardiac arrhythmias, heart rate, respiratory rate, and other vital signs using artificial intelligence. The patch's Band-Aid-such as design enhances patient comfort and compliance. This investment, led by Ally Bridge Group with support from EW Healthcare Partners, MVM, and Revelation Partners, aims to expand VitalConnect's reach in both outpatient and inpatient settings, positioning the company to compete with established players such as iRhythm Technologies
- In January 2025, Smart Meter announced significant growth in its remote patient monitoring (RPM) services, achieving a 300% increase in sales since 2022 and quadrupling its commercial customer base. The company now serves over 350,000 patients daily through its cellular-enabled devices. To support this expansion, Smart Meter has relocated to a new 25,000-square-foot facility in Tampa, Florida, consolidating operations and enhancing service capabilities. In addition, the company has enhanced its SmartTouch patient engagement solutions, which have been shown to increase patient adherence and qualifying reimbursement by 52%. These developments position Smart Meter as a leader in the RPM industry, demonstrating its commitment to innovation and improved patient outcomes
